Scientists review 'metabolite damage-control' to understand how cells repair damaged metabolites and prevent fatal diseases. The field is in its infancy, with many unidentified reactions waiting discovery.
Survivors of heart attacks are three times more likely to develop depression due to their thought pattern about the event. Addressing threat perception through psychological interventions can help reduce this risk and promote a smoother recovery.
Scientists at the University of Luxembourg have developed a new calculation technique that accurately predicts the B-Z transition in DNA, which can lead to cancer. The breakthrough enables the prediction of material properties such as melting temperatures and elasticity with high accuracy.
Researchers at AxoGlia Therapeutics and the Luxembourg Centre for Systems Biomedicine have received a grant to identify new neuroprotective therapeutic targets for Parkinson's disease. The project aims to disrupt the CD40/CD40-Ligand neuroinflammatory pathway, which could lead to new avenues for therapeutic interventions.
The LLLight'in'Europe project aims to measure employee strengths in solving complex problems, fostering innovation and attracting new talent. The four-year study will assess Complex Problem Solving Skills (CPS) capabilities in 4150 individuals across Europe.
Research published in The FASEB Journal found that changes in gravity during animal development affect antibody production and white blood cell regeneration. This could have significant implications for understanding human diseases such as cancer and diabetes.
Researchers at University of Luxembourg develop method to observe and prevent solar cell degradation before production, improving industry efficiency. Thin film solar cells can be degraded during production, but new findings show it's reversible with quick treatment.